MG
MNOV icon

Mather Group’s MediciNova MNOV Stock Holding History

Mather Group’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$73 – 2004
2024
Q2 		$73 Buy
+50
New +$70 ﹤0.01% 2156

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mather Group's MNOV Position: Q3 2024 in Review

Mather Group sold out of MediciNova (MNOV) in Q3 2024, closing a stake of 50 shares — an estimated $73 sold.

Mather Group first reported a position in MNOV in Q2 2024 and held it in 1 quarter. The position peaked at $73 in Q2 2024. 30 funds tracked by Wall St. Rank hold MNOV as of Q3 2024.

  • Mather Group reported no remaining MediciNova position as of Q3 2024 after selling out during the quarter.
  • Mather Group sold 50 MediciNova shares in Q3 2024, an estimated $73.
  • Mather Group first reported a position in MediciNova in Q2 2024 and held it in 1 quarter.
  • Mather Group's MediciNova position peaked at $73 in Q2 2024.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q3 2024.

Based on Mather Group's 13F filing for Q3 2024, filed 7 Oct 2024.